Advertisement
Abstract

Influence of the degree of renal dysfunction on the pharmacokinetic properties of the novel recombinant plasminogen activator reteplase in rats.

U Martin, L Doerge, K Stegmeier and B Müller-Beckmann
Drug Metabolism and Disposition March 1996, 24 (3) 288-292;
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Abstract

Influence of the degree of renal dysfunction on the pharmacokinetic properties of the novel recombinant plasminogen activator reteplase in rats.

U Martin, L Doerge, K Stegmeier and B Müller-Beckmann
Drug Metabolism and Disposition March 1, 1996, 24 (3) 288-292;
Twitter logo Facebook logo Mendeley logo

Jump to section

Related Articles

Cited By...

Similar Articles

Advertisement